| Role of progestins in contraception. | |
| | |
MedLine Citation:
|
PMID: 15715527 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Progestins have been used for contraception for more than 30 years. The main goal was to develop a contraceptive method devoid of the metabolic or clinical side-effects associated with the use of estrogens. The development of new contraceptive methods and formulations is time-consuming and requires devotion, belief, and also strong economical basis. As a result of this endeavor new methods have been developed: oral progestins, implants, injectables, intrauterine hormonal systems, and vaginal rings. Progestin-only contraceptives may be preferable in some situations, which have absolute or relative contraindications to estrogen, side-effects to estrogen containing hormonal contraception, lactation, and comfort and feasibility of formulations for long-term use. At present, emergency contraception is also performed with progestin. |
| | |
Authors:
|
Risto Erkkola; Britt-Marie Landgren |
Related Documents
:
|
18372257 - The cost-effectiveness of long-acting reversible contraceptive methods in the uk: analy... 8200877 - The effect of price increases on contraceptive sales in bangladesh. 3318467 - Updated pregnancy rates for the today contraceptive sponge. 16281297 - Pregnancy in dystonic women with in situ deep brain stimulators. 23312717 - A viable foal obtained by equine somatic cell nuclear transfer using oocytes recovered ... 2910377 - Diurnal variation in admission to hospital of women in labour. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Acta obstetricia et gynecologica Scandinavica Volume: 84 ISSN: 0001-6349 ISO Abbreviation: Acta Obstet Gynecol Scand Publication Date: 2005 Mar |
Date Detail:
|
Created Date: 2005-02-17 Completed Date: 2005-03-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0370343 Medline TA: Acta Obstet Gynecol Scand Country: Denmark |
Other Details:
|
Languages: eng Pagination: 207-16 Citation Subset: IM |
Affiliation:
|
Department of Obstetrics and Gynecology, University Central Hospital, Turku, Finland. risto.erkkola@tyks.fi |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cervix Mucus
/
drug effects Contraception / methods* Contraceptive Agents, Female / adverse effects, pharmacology* Contraceptive Devices, Female* Contraceptives, Oral Contraceptives, Oral, Combined Drug Implants Endometrium / drug effects Fallopian Tubes / drug effects Female Humans Intrauterine Devices Ovulation / drug effects Progesterone Congeners / adverse effects, pharmacology*, physiology Reproductive Control Agents / administration & dosage, adverse effects |
| Chemical | |
Reg. No./Substance:
|
0/Contraceptive Agents, Female; 0/Contraceptives, Oral; 0/Contraceptives, Oral, Combined; 0/Drug Implants; 0/Progesterone Congeners; 0/Reproductive Control Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Application of RNA interference to study stem cell function: current status and future perspectives.
Next Document: Normal labor associated with changes in uterine heparan sulfate proteoglycan expression and localiza...